BioSpace News Archive

FDA

Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression

New Indication Makes VRAYLAR First and Only Dopamine and Serotonin Partial Agonist to Treat the Full Spectrum of Bipolar I Symptoms in Manic, Mixed, and Depressive Episodes

May 28, 2019
·
14 min read
Bio NC

Aerie Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

Aerie Pharmaceuticals, Inc. announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019 at 2:30 p.m. Eastern Time in New York, NY.

May 28, 2019
·
2 min read
Policy

ATUM Licenses Exclusive Access to Proprietary Gene-Coding Algorithm for Plant-Based Recombinant Protein Expression to Medicago

ATUM announced the exclusive licensing of gene-coding algorithm GeneGPS® to optimize protein expression in Nicotiana benthamiana to Medicago, a global leader in the development and production of plant-derived vaccines and therapeutic proteins.

May 28, 2019
·
2 min read
Business

Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics

Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain.

May 28, 2019
·
4 min read
Job Trends

Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

SOURCE EXPLORER announced that it has accumulated over 3,000 clients and is taking a firm launch into the global marketplace.

May 28, 2019
·
2 min read
Business

iWave and Gravyty Expand Strategic Partnership to Elevate Grateful Patient Programs

iWave and Gravyty, leaders in fundraising enablement and efficiency, have expanded their strategic partnership.

May 28, 2019
·
3 min read
Pharm Country

GRYT Health Hosts Inaugural 2019 Global Virtual Cancer Conference (GVCC19) to Drive Collaboration and Improve Cancer-Related Outcomes and Experiences

First Conference of Its Kind to Bring Together Patients, Survivors, Caregivers, Non-Profits, Healthcare Providers, Hospital Systems and Industry Professionals

May 28, 2019
·
5 min read
Pharm Country

CELLSEARCH Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

May 28, 2019
·
6 min read
World First Test Breakthrough to Boost IVF Success Rates

A new revolutionary non-invasive embryo screening test will reduce miscarriages and the time it takes to achieve a healthy live birth for the one-in-six Australian couples affected by infertility.

May 28, 2019
·
3 min read
Business

StillCanna Signs Definitive Agreement With BioSciences Enterprises to Supply C$36 Million Worth of CBD Isolate and Implements a Two-Stage Extraction Plan for Poland

StillCanna Inc. is pleased to announce that further to its press release dated March 28, 2019, it has signed a definitive agreement to supply Bioscience Enterprises of California with up to C$36,000,000 worth of CBD Isolate.

May 28, 2019
·
7 min read